Sponsor or institution

Clinical trials and research at Jiangxi Provincial Cancer Hospital

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Chlorhexidine spray to prevent radiation skin damage during nasopharyngeal cancer treatment

  This trial will test whether applying a 2% chlorhexidine spray during chemoradiotherapy reduces skin irritation and improves quality of life for people with stage II–III nasopharyngeal cancer.

  Recruiting Phase 3 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT07559877

• High-low dose radiation plus anti-PD-1 followed by full-course radiation for recurrent nasopharyngeal cancer

  This approach tests whether a short induction of mixed low- and high-dose radiation with an anti-PD-1 drug, followed by full-course radiation and immunotherapy maintenance, can shrink recurrent nasopharyngeal cancer in patients who cannot have surgery.

  Recruiting Phase 2 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT07277764

• Nutritional management during chemoradiotherapy for nasopharyngeal cancer

  This study will test whether an immune‑enhancing oral nutritional supplement given throughout concurrent chemoradiotherapy helps adults with stage II–IVa nasopharyngeal cancer maintain weight, preserve lymphocyte counts, and reduce treatment side effects.

  Recruiting Phase 2 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT07085988

• Optimizing radiotherapy to protect thyroid function in nasopharyngeal carcinoma patients

  This study is testing whether a new way of giving radiotherapy can better protect the thyroid gland in patients with nasopharyngeal cancer compared to the standard treatment.

  Recruiting Phase 3 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT06752239

• Combining Toripalimab with Capecitabine for High-Risk Nasopharyngeal Carcinoma

  This study is testing if combining toripalimab with capecitabine can help high-risk nasopharyngeal cancer patients avoid cancer coming back after their initial treatment.

  Recruiting at 2 sites Phase 3 Jiangxi Provincial Cancer Hospital · Ganzhou, Jiangxi and 2 other locations · NCT06277050

• Evaluating the impact of chemotherapy response in nasopharyngeal carcinoma

  This study is trying to see if how well patients with advanced nasopharyngeal carcinoma respond to the first round of chemotherapy can give clues about their future health and immune system changes.

  Recruiting Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT06182657

• Combination of Anlotinib and TQB2450 for Esophageal Cancer Treatment

  This study is testing if combining two medications, Anlotinib and TQB2450, can help people with esophageal cancer stay cancer-free after surgery.

  Recruiting Phase 2 Jiangxi Provincial Cancer Hospital · Nanchang, Jiangxi · NCT05252078

Quick answers

How many clinical trials run by Jiangxi Provincial Cancer Hospital are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →